18F-FDG-PET/CT与心脏CTA在疑似经导管主动脉瓣感染性心内膜炎中的附加价值
该多中心回顾性分析纳入30例疑似经导管主动脉瓣感染性心内膜炎(TAVI-IE)患者,所有患者均行18F-FDG-PET/CT,其中14/30行心脏CTA。在改良Duke标准基础上联合18F-FDG-PET/CT和CTA后,10/22例「可能」病例被重新分类为「确诊」(5/22)或「排除」(5/22),最终诊断改变见于33%的患者。
要点
- 疑似TAVI-IE仅凭Duke标准难以诊断,联合18F-FDG-PET/CT和CTA可提高分类准确性。
- 联合影像使10/22例「可能」病例重新分类为确诊或排除,最终诊断改变见于33%患者。
- 18F-FDG-PET/CT在所有患者中应用,心脏CTA仅14/30例,提示PET/CT应用更普遍。
核心结论
- 联合18F-FDG-PET/CT和/或CTA改变了33%疑似TAVI-IE患者的最终诊断,是有价值的诊断工具。
研究设计与样本
- 多中心回顾性分析纳入30例疑似TAVI-IE患者,所有患者行18F-FDG-PET/CT,14/30例行心脏CTA。
- 患者先按Duke标准分类,联合18F-FDG-PET/CT和CTA后按ESC标准分类,最终诊断由心内膜炎团队依据ESC指南确定。
主要发现
- 改良Duke标准分类:排除3%(1/30)、可能73%(22/30)、确诊23%(7/30)。
- 联合18F-FDG-PET/CT和CTA后,22例「可能」病例中10例重新分类:5/22为「确诊TAVI-IE」,5/22为「排除TAVI-IE」。
- 最终诊断变为:排除20%(6/30)、可能40%(12/30)、确诊40%(12/30)。
关键数值与推荐
- 改良Duke标准:排除1/30(3%)、可能22/30(73%)、确诊7/30(23%)。
- 联合影像后最终诊断:排除6/30(20%)、可能12/30(40%)、确诊12/30(40%)。
- 联合影像使10/22例「可能」病例重新分类为确诊(5/22)或排除(5/22)。
临床怎么用
- 对疑似TAVI-IE且Duke标准仅分类为「可能」的患者,可联合18F-FDG-PET/CT和心脏CTA以辅助确诊或排除。
局限性
- 回顾性多中心设计,样本量仅30例,其中心脏CTA仅14/30例完成,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: Transcatheter-implanted aortic valve infective endocarditis (TAVI-IE) is difficult to diagnose when relying on the Duke Criteria. Our aim was to assess the additional diagnostic value of 18F-fluorodeoxyglucose (18F-FDG) positron emission/computed tomography (PET/CT) and cardiac computed tomography angiography (CTA) in suspected TAVI-IE. METHODS: A multicenter retrospective analysis was performed in all patients who underwent 18F-FDG-PET/CT and/or CTA with suspected TAVI-IE. Patients were first classified with Duke Criteria and after adding 18F-FDG-PET/CT and CTA, they were classified with European Society of Cardiology (ESC) criteria. The final diagnosis was determined by our Endocarditis Team based on ESC guideline recommendations. RESULTS: Thirty patients with suspected TAVI-IE were included. 18F-FDG-PET/CT was performed in all patients and Cardiac CTA in 14/30. Using the Modified Duke Criteria, patients were classified as 3% rejected (1/30), 73% possible (22/30), and 23% definite (7/30) TAVI-IE. Adding 18F-FDG-PET/CT and CTA supported the reclassification of 10 of the 22 possible cases as "definite TAVI-IE" (5/22) or "rejected TAVI-IE" (5/22). This changed the final diagnosis to 20% rejected (6/30), 40% possible (12/30), and 40% definite (12/30) TAVI-IE. CONCLUSIONS: Addition of 18F-FDG-PET/CT and/or CTA changed the final diagnosis in 33% of patients and proved to be a valuable diagnostic tool in patients with suspected TAVI-IE.
引用
- Wahadat AR, Tanis W, Swart LE, et al. Added value of 18F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis. J Nucl Cardiol. 2019. PMID: 31792918. doi:10.1007/s12350-019-01963-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。